Instead, we found one mutation (PIK3CAE542K; HCC041; https://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7/) that has been implicated with lacking drug response to anti-epidermal growth factor (EGFR) antibodies [71]. The gene discussed is EGF; the disease is lung cancer.